Illerhaus, Gerald <br/><br/>
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.  [electronic resource] 

 -  The Lancet. Haematology  Aug 2016 
 - e388-97 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>2352-3026 
<br/><br/><label>Standard No.: </label>10.1016/S2352-3026(16)30050-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carmustine--administration & dosage<br/>Central Nervous System Neoplasms--diagnosis<br/>Combined Modality Therapy<br/>Female<br/>Follow-Up Studies<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Lymphoma, Non-Hodgkin--diagnosis<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Prognosis<br/>Prospective Studies<br/>Rituximab--administration & dosage<br/>Survival Rate<br/>Thiotepa--administration & dosage<br/>Transplantation, Autologous<br/>Young Adult